Cleared Special

K213632 - Instylla Delivery Kit (FDA 510(k) Clearance)

Feb 2022
Decision
85d
Days
Class 2
Risk

K213632 is an FDA 510(k) clearance for the Instylla Delivery Kit. This device is classified as a Syringe, Piston (Class II - Special Controls, product code FMF).

Submitted by Instylla, Inc. (Bedford, US). The FDA issued a Cleared decision on February 10, 2022, 85 days after receiving the submission on November 17, 2021.

This device falls under the General Hospital FDA review panel. Regulated under 21 CFR 880.5860.

Submission Details

510(k) Number K213632 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 17, 2021
Decision Date February 10, 2022
Days to Decision 85 days
Submission Type Special
Review Panel General Hospital (HO)
Summary Summary PDF

Device Classification

Product Code FMF - Syringe, Piston
Device Class Class II - Special Controls
CFR Regulation 21 CFR 880.5860

Similar Devices - FMF Syringe, Piston

All 21
Profoject™ Insulin Syringes
K253068 · CMT Health PTE., Ltd. · Feb 2026
Verisafe Safety Retractable Insulin Syringes
K250192 · Promisemed Hangzhou Meditech Co., Ltd. · Dec 2025
Merit Syringe
K250853 · Merit Medical Systems, Inc. · Nov 2025
Monoject™ 1mL Tuberculin Syringe Luer-Lock Tip (1180100777)
K243660 · Cardinalhealth · Aug 2025
BD Plastipak™ Syringe
K251350 · Becton, Dickinson and Company · Jul 2025
GraftGun Universal Graft Delivery System (GDS)
K243580 · SurGenTec, LLC · Feb 2025